CPWA
GILD icon

Cerro Pacific Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Cerro Pacific Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,733
Closed -$252K – 164
2025
Q1 		$252K Sell
2,733
-275
-9% -$28.4K 0.08% 139
2024
Q4 		$252K Sell
3,008
-4,721
-61% -$425K 0.08% 138
2024
Q3 		$530K Hold
7,729
– – 0.2% 98
2024
Q2 		$530K Buy
+7,729
New +$516K 0.2% 99

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cerro Pacific Wealth Advisors's GILD Position: Q2 2025 in Review

Cerro Pacific Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 2,733 shares — an estimated $252K sold.

Cerro Pacific Wealth Advisors first reported a position in GILD in Q2 2024 and held it in 4 quarters. The position peaked at $530K in Q3 2024. 2,026 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Cerro Pacific Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Cerro Pacific Wealth Advisors sold 2,733 Gilead Sciences shares in Q2 2025, an estimated $252K.
  • Cerro Pacific Wealth Advisors first reported a position in Gilead Sciences in Q2 2024 and held it in 4 quarters.
  • Cerro Pacific Wealth Advisors's Gilead Sciences position peaked at $530K in Q3 2024.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Cerro Pacific Wealth Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.